Header Logo

Connection

Ricardo Perez to Triple Negative Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Ricardo Perez has written about Triple Negative Breast Neoplasms.
Ricardo Perez
Connection Strength
0.687
Triple Negative Breast Neoplasms
  1. Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther. 2020 11 01; 21(11):1033-1040.
    View in: PubMed
    Score: 0.687
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.